Both in Pharmaceuticals
Regeneron Pharmaceuticals vs Royalty Pharma
Over the past year REGN returned +44.5% and RPRX returned +80.1%; their daily moves had a correlation of 0.43.
REGN +44.5% RPRX +80.1%Growth of $1, one year, split-adjusted
| Metric | REGN | RPRX |
|---|---|---|
| Price | $927.89 | $67.18 |
| Market cap | $95.99B | $29.91B |
| Today | +13.33% | +1.90% |
| 1 month | +26.3% | +16.6% |
| 6 months | +32.3% | +35.8% |
| Year to date | +20.2% | +73.9% |
| 1 year | +42.1% | +83.2% |
| Revenue growth (YoY) | +36.3% | +16.5% |
| Gross margin | 88.8% | 100.0% |
| Net margin | 38.1% | 2.7% |
| P/E (TTM) | 19.9× | 36.7× |
| Price / sales | 5.7× | 11.8× |
| Net cash | $6.59B | -$8.23B |
| Dividend yield | 0.41% | 1.40% |
| Volatility (60d) | 37.0% | 24.9% |
| Short % of float | 2.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).